Non-applicability of Statement of Deviation or variation under Regulation 32 of SEBI (LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences Ltd has informed BSE that the Statement of Deviation or Variation under SEBI's Listing Obligations and Disclosure Requirements is not applicable to the company. The company confirms it has not raised any funds through a public issue, rights issue, preferential issue, or Qualified Institutions Placement (QIP). As there were no fund-raising activities, there is nothing to report in terms of deviation or variation in the use of proceeds. The filing is signed by the Company Secretary & Compliance Officer, Siddhi Shah.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms the company did not undertake any recent fund-raising activity that would require deviation reporting.